Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 10Cholangiocarcinoma 8Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Neoplasms 2Gallbladder Neoplasms 2Pancreatic Cancer Metastatic to Liver 1Klatskin Tumor 1Gastrointestinal Neoplasms 1Fistula 1Disease 1Choledocholithiasis 1Cholangitis, Sclerosing 1Biliary Tract Diseases 1Biliary Fistula 1Bile Duct Diseases 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Gastrointestinal × Clear all
NCT05994521 2024-10-01

INTERCEPT

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Recruiting
110 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡